guest ::
| Home > Publications database > Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression. |
| Home > Publications database > Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression. |
| Journal Article | DKFZ-2026-01341 |
; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
2026
Nature Publishing Group
London
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumor characterized by its ability to create an immunosuppressive tumor microenvironment. Here, using robust 3D co-culture systems, samples from PDAC patients and murine in vivo models, we described a novel immune evasion mechanism used by PDAC to inhibit the anti-tumor activity of B lymphocytes: We provide evidence that pancreatic cancer suppresses the B cell-specific transcriptional program while enforcing their reprogramming into functional macrophages. Thus, we hypothesize that B cells undergo transdifferentiation under the influence of PDAC, by losing their lymphoid identity and acquiring a myeloid immunosuppressive phenotype. This drastic change is enacted by the loss of Pax5 expression. Importantly, our results showed that the Ex-B cells efficiently become phagocytic and produce soluble proteins that are known to enhance cancer cell survival and proliferation. This suggests that the PDAC-induced B cell to macrophage transdifferentiation pathway is functionally relevant and hence could serve as an immunotherapeutic target.
; 
; 
; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DOAJ Seal ; Essential Science Indicators ; Fees ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
